FIGSFIGS
FIGS
About: FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.
Employees: 316
0
Funds holding %
of 7,457 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
756% more call options, than puts
Call options by funds: $6.81M | Put options by funds: $796K
100% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]
21.36% more ownership
Funds ownership: 74.5% [Q4 2024] → 95.86% (+21.36%) [Q1 2025]
7% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 28
4% less funds holding
Funds holding: 170 [Q4 2024] → 163 (-7) [Q1 2025]
8% less capital invested
Capital invested by funds: $745M [Q4 2024] → $684M (-$60.4M) [Q1 2025]
19% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 57
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3.75
20%
downside
Avg. target
$4.50
4%
downside
High target
$5
7%
upside
4 analyst ratings
0 positive
0%
3 neutral
75%
1 negative
25%
Barclays Adrienne Yih 28% 1-year accuracy 19 / 69 met price target | 7%upside $5 | Equal-Weight Maintained | 13 May 2025 |
Telsey Advisory Group Dana Telsey 49% 1-year accuracy 90 / 184 met price target | 7%upside $5 | Market Perform Maintained | 13 May 2025 |
Goldman Sachs Brooke Roach 68% 1-year accuracy 26 / 38 met price target | 20%downside $3.75 | Sell Maintained | 22 Apr 2025 |
Morgan Stanley Lauren Schenk 86% 1-year accuracy 18 / 21 met price target | 9%downside $4.25 | Equal-Weight Maintained | 17 Apr 2025 |
Financial journalist opinion
Based on 5 articles about FIGS published over the past 30 days
Neutral
Seeking Alpha
1 week ago
FIGS, Inc. (FIGS) Q1 2025 Earnings Call Transcript
FIGS, Inc. (NYSE:FIGS ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder and Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Matt Koranda - ROTH Capital Brooke Roach - Goldman Sachs Rick Patel - Raymond James Brian Nagel - Oppenheimer Dana Telsey - Telsey Group Nathan Feather - Morgan Stanley Lorraine Hutchinson - Bank of America Operator Good afternoon. Thank you for attending today's FIGS First Quarter Fiscal 2025 Earnings Conference Call.
Positive
Zacks Investment Research
1 week ago
Compared to Estimates, Figs (FIGS) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neutral
Zacks Investment Research
1 week ago
Figs (FIGS) Reports Break-Even Earnings for Q1
Figs (FIGS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.
Neutral
Business Wire
1 week ago
FIGS Releases First Quarter 2025 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2025 Financial Highlights Net revenues were $124.9 million, an increase of 4.7% year over year, primarily due.
Positive
Seeking Alpha
2 weeks ago
Baron Focused Growth Fund Q1 2025 Top Contributors And Detractors
xAI Holdings' leading AI model Grok 3 outperformed competitors, bolstered by the Colossus data center and Twitter acquisition, enhancing data integration and corporate alignment. Spotify delivered strong performance driven by margin improvements, user growth, and product innovation, positioning it as a long-term winner in music streaming. Guidewire Software is poised to capture significant market share in the P&C insurance software industry.
Neutral
Business Wire
1 month ago
FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 fin.
Neutral
Seeking Alpha
1 month ago
Stock Picks From Seeking Alpha's March 2025 New Analysts
In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and investment strategies. Our analysts covered a diverse set of industries—including IT, financials, utilities, materials, and mining—and provided ratings ranging from Strong Sell to Strong Buy. Top picks include C3.ai, Robinhood, Central Puerto, CF Industries, and Kyndryl.
Neutral
Business Wire
1 month ago
FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the “Board”), effective April 1, 2025 (the “Effective Date”). Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Co.
Positive
Seeking Alpha
2 months ago
Figs, Inc. - Slow Growth Is Still Growth
Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO.
Neutral
Seeking Alpha
2 months ago
FIGS Shows Significant U.S. Weakness But Continues To Trade At 50x NOPAT
FIGS, Inc.'s earnings show mixed results, with strong international growth but declining U.S. sales and weak FY25 guidance, raising concerns about profitability and customer acquisition. Despite strong product innovation, FIGS struggles with high marketing costs, poor customer acquisition, and stagnating U.S. sales, making its high valuation unjustifiable. International expansion is promising but comes with lower margins; new management might improve execution, but significant challenges remain.
Charts implemented using Lightweight Charts™